Beam time allocations
Scientific merit of applications for beamtime assessed.
Showing 81 - 100 of 124 results
Scientific merit of applications for beamtime assessed.
Second half of 2018
Both the Australian Centre for Neutron Scattering and the National Deuteration Facility share in grants
Monash University researchers have used advanced techniques at ANSTO to investigate the production of new, elongated polymer nanocapsules with a high payload of drug nanocrystals to potentially increase drug targetability, and also decrease dosage frequency and side effects.
Government response to 2016 National Research Infrastructure Roadmap
ANSTO is a major supplier of Australia’s radioactive isotopes used in nuclear medicine, delivering around 10,000 patient doses each week. Health-based research and development in Australia and overseas also benefit greatly from ANSTO’s unique capabilities and expertise in the detection, diagnosis and treatment of disease using nuclear and accelerator infrastructure.
ANSTO leverages great science to deliver big outcomes. We partner with scientists and engineers and apply new technologies to provide real-world benefits. Our work improves human health, saves lives, builds our industries and protects the environment.
Robert Russell has been awarded his PhD
Role at ANSTO
Explore ANSTO's range of publications and reports available for the public.
Three ANSTO scientists are contributing to two recently awarded Australian Research Council Discovery Project grants.
ANSTO’s Lucas Heights campus has an extensive range of specialised facilities and capabilities that are available to assist industry-based professionals in solving problems. Please contact us to discuss how we can assist you. We are open to entering into commercial arrangement with appropriate partners.